Skip to main content
. 2011 Nov 16;61(6):865–879. doi: 10.1007/s00262-011-1149-5

Fig. 2.

Fig. 2

CLL-specific immune responses in cohort I, II, and III. a IFN-γ ELISPOT and b lymphocyte proliferation assay in the individual patients comparing pre-vaccination and follow-up. * indicates leukemia-specific immune response; (+) indicates response meeting the criteria for a vaccine-induced immune response (see “Patients and methods” for definition). SFC spot-forming cells, CPM count per minute